Eyenovia is looking to raise up to $35 million in an initial public offering, according to recent filings. The company plans to use the funds to support trials of its device, which is designed to deliver small doses of drugs to the eye. The New York-based company uses a piezo-electric dispensation technology to deliver microdoses of […]
Optical/Ophthalmic
Glaukos wins FDA nod for IDE trial of iStent SA
Glaukos (NYSE:GKOS) said today it won FDA investigational device exemption to launch a pivotal study of its iStent SA trabecular micro-bypass system designed to treat glaucoma. The San Clemente, Calif.-based company’s iStent SA is designed to reduce intraocular pressure in psuedophakic, mild-to-moderate open-angle, pigmentary or psuedoexfoliative glaucoma patients, the company said. The system includes 2 micro-scale […]
Aerie’s glaucoma eye drops win early FDA nod
Aerie Pharmaceuticals (NSDQ:AERI) won an early FDA nod for its glaucoma drug, Rhopressa. The agency was slated to make a decision about the company’s eye drops in February. The win for Aerie came after an expert panel voted 9-1 in the drug’s favor. Studies have found that Rhopressa lowers elevated intraocular pressure in the eye, but analysts have […]
Novaliq’s NovaTears, Omega-3 combo approved in Europe for evaporative dry eye disease
Privately-held pharma company Novaliq GmbH said this week that its NovaTears+Omega-3 combo therapy for patients with evaporative dry disease was registered in Europe. The treatment uses Novaliq’s water-free EyeSol drug delivery tech and is available in a multi-dose bottle. The company touted its product as the first eye drop to contain high concentrations of Omega-3 ethyl ester. […]
Second Sight launches Argus retinal prosthesis in Iran
Second Sight Medical (NSDQ:EYES) said today it launched its Argus II retinal prosthesis system in Iran, facilitated through its exclusive distribution partner Arshia Gostar Darman. The Sylmar, Calif.-based company said that the system has been implanted in two patients in the country, with the procedures performed by Dr. Mohsen Farvadin at the Shiraz Pars Hospital and Khalili […]
RxSight wins FDA nod for light-adjustable IOL
The FDA has cleared RxSight‘s implantable light adjustable intraocular lens and light delivery device. The company’s RxSight IOL is designed from a UV light reactive material meant to be treated by a specific Light Delivery Device, intended for use 17 to 21 days post-procedure. The lens is designed to be treated by 3-4 light treatments […]
Restasis buyers level antitrust lawsuit against Allergan
A proposed class of Restasis buyers filed an antitrust suit last week in a Texas federal court against Allergan (NYSE:AGN), according to reports from Law360. The suit accuses Allergan of blocking generics to its dry-eye drug using tactics like sham infringement suits and a controversial deal with a Native American tribe. Get the full story at our sister […]
Cambridge Consultants prototypes miniaturized robot for cataract surgery
Cambridge Consultants showed off its prototype of a miniaturized robot designed for cataract surgery last week at its annual Innovation Day event. The system, Axsis, is one of the smallest known robots for surgical use, according to the firm, featuring instruments of just 1.8mm in diameter. Get the full story at our sister site, The […]
Staar Surgical plans pivotal of Visian EVO ICL presbyopia optic for Q1 2018
Staar Surgical (NSDQ:STAA) this week reported results from the feasibility clinical study of its Evo+ Visian ICL with aspheric optics designed to reduce presbyopia, and that based on the results it plans to launch a pivotal clinical study of the device during the 1st quarter next year. The Monrovia, Calif.-based company’s EVO+ Visian ICL is designed […]
Implandata Ophthalmic touts 1st-in-human use of next-gen Eyemate IOP sensor
Implandata Ophthalmic Products today touted the first-in-human use of its next-gen Eyemate micro-sensor implant designed to monitor intraocular pressure. The Eyemate microsensor is designed for the continuous monitoring of intraocular pressure and can be checked remotely, removing the need for a patient to visit a doctor’s office for measurements, the Hannover, Germany-based company said. “This […]
iVeena finishes pilot trial of sustained-release implant
iVeena Delivery Systems said earlier this month that it finished a pilot trial for its IVMED-10 bioerodible implant designed to treat pain and inflammation after cataract surgery. Placed during cataract surgery, the sustained-release implant delivers dexamethasone for two weeks from the lens capsule. Get the full story at our sister site, Drug Delivery Business News.